Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04616612 · ClinicalTrials.gov registry record · NA
Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT04616612 is a NA study that has completed, run by Indiana University. The registered enrollment target is 150 participants.
The verdict
NCT04616612, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this 2-group, randomized, controlled trial is to evaluate the refined SystemCHANGE™ against attention control patient education in CKD patients taking RAAS medications.
Interventions
- OTHER Attention Control
- BEHAVIORAL SystemCHANGE (TM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-12-15 |
| Est. Completion | 2024-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04616612
The ClinicalTrials.gov registry entry for NCT04616612 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT04616612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04616612 about?
NCT04616612 is a clinical study titled "Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study". The purpose of this 2-group, randomized, controlled trial is to evaluate the refined SystemCHANGE™ against attention control patient education in CKD patients taking RAAS medications.
What is the current status of trial NCT04616612?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2021-12-15. Estimated completion is 2024-02-06.
What interventions are being tested in trial NCT04616612?
The interventions under investigation include: Attention Control (OTHER), SystemCHANGE (TM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04616612?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.